Stay updated on PF-06439535 vs Bevacizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the PF-06439535 vs Bevacizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PF-06439535 vs Bevacizumab in NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-04-30T14:12:22.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed descriptions of a Phase 3 clinical trial for non-small cell lung cancer and the associated inclusion and exclusion criteria. Additionally, a new revision number has been added.
    Difference
    5%
    Check dated 2025-04-16T07:22:00.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.0%
    Check dated 2025-04-09T01:41:05.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.0%
    Check dated 2025-03-31T18:56:27.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.6%
    Check dated 2025-02-20T12:55:49.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    The website has updated to revision v2.14.2, noting that some NLM-NCBI services are experiencing heavy traffic, which may impact performance and availability.
    Difference
    0.7%
    Check dated 2025-02-06T06:44:31.000Z thumbnail image

Stay in the know with updates to PF-06439535 vs Bevacizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PF-06439535 vs Bevacizumab in NSCLC Clinical Trial page.